The company is incorporated in Delaware.
The company’s fiscal year ends December 31st.
Our common stock is listed on the NASDAQ Global Market under the symbol “XFOR”
X4 does not pay a dividend or offer a dividend reinvestment program.
98420X202
The transfer agent and registrar for the common stock of X4 Pharmaceuticals, Inc. stock is:
Computershare Trust Company, N.A.
250 Royall Street
Canton, Massachusetts 02021
(800) 962-4284
For questions about your stock please contact our transfer agent, Computershare Trust Company, N.A.
To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, Computershare Trust Company, N.A., 250 Royall Street, Canton, Massachusetts 02021.
To transfer stock or replace a lost stock certificate, contact our transfer agent, Computershare Trust Company, N.A.
The auditor for X4 is PricewaterhouseCoopers.
Legal counsel for X4 is Goodwin Procter LLP.
To find out more about X4 visit our website at www.x4pharma.com.
X4’s press release archive can be viewed under the “News Releases” section of the “Investors” page and financial reports are available under the “SEC Filings” section of the “Investors” page.
X4’s SEC Filings can be found on www.sec.gov and are also available under the “SEC Filings” section of the “Investors” page located at our website www.x4pharma.com.
For a list of the Executive Management team and Board of Directors please visit the “About” page of our website.